Brainsway (BWAY) CTO sells 5,000 shares after exercising options
Rhea-AI Filing Summary
Brainsway Ltd. Chief Technology Officer Moiseyev Gilad reported multiple equity transactions. On May 25, 2026, he exercised stock options for 7,500 Ordinary Shares at an exercise price of NIS 11.17 per share, and the company retained 1,902 shares at NIS 44.04 per share to cover the option exercise.
On June 15, 2026, he sold 5,000 Ordinary Shares in an open-market transaction at a sale price of NIS 42.0397 per share, leaving him with 53,098 Ordinary Shares held directly. Footnotes indicate remaining stock options to purchase 13,125 Ordinary Shares vesting in equal quarterly installments until March 5, 2028, alongside additional unvested RSUs that settle in Ordinary Shares over future dates.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
4 txns
Insider
Moiseyev Gilad
Role
Chief Technology Officer
Sold
5,000 shs ($0.00)
Approx. gross sale proceeds
$0.00
Approx. exercise cost
$0.00
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares | 5,000 | $0.00 | $0.00 |
| Exercise | Stock Options (right to buy) | 7,500 | $0.00 | $0.00 |
| Exercise | Ordinary Shares | 7,500 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Ordinary Shares | 1,902 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Options (right to buy) — 22,500 shares (Direct);
Ordinary Shares — 53,098 shares (Direct)
Footnotes (6)
- F1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- F2. The exercise price is NIS 11.17 per share.
- F3. This figure includes ordinary shares and unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 6,563 ordinary shares vesting in equal quarterly installments until March 5, 2028, (b) RSUs to receive 10,000 ordinary shares with 2,500 vesting on November 10, 2026 and the remainder vesting in equal quarterly installments until November 10, 2029 and (c) RSUs to receive 27,500 ordinary shares with 6,875 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030.
- F4. These shares were retained by the Company at a price of NIS 44.04 per share in payment of the exercise price of the employee stock options exercised by the Reporting Person.
- F5. The sale price was NIS 42.0397 per share.
- F6. Stock options were granted on March 5, 2024, with the remaining options to purchase 13,125 ordinary shares vesting in equal quarterly installments until March 5, 2028.
Key Figures
Shares sold: 5,000 Ordinary Shares
Sale price: NIS 42.0397 per share
Options exercised: 7,500 Ordinary Shares
+4 more
7 metrics
Shares sold
5,000 Ordinary Shares
Open-market sale on June 15, 2026
Sale price
NIS 42.0397 per share
Price for 5,000-share sale on June 15, 2026
Options exercised
7,500 Ordinary Shares
Option exercise on May 25, 2026
Exercise price
NIS 11.17 per share
Exercise price for 7,500 options
Shares retained by company
1,902 Ordinary Shares
Retained at NIS 44.04 per share for exercise payment
Post-transaction holdings
53,098 Ordinary Shares
Direct ownership after June 15, 2026 sale
Remaining options
13,125 Ordinary Shares
Options vesting quarterly until March 5, 2028
Key Terms
American Depositary Shares, restricted stock units ("RSUs"), tax liability, Stock options
4 terms
restricted stock units ("RSUs") financial
"This figure includes ordinary shares and unvested restricted stock units ("RSUs"), with each RSU representing a contingent right..."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
tax liability financial
"Payment of exercise price or tax liability by delivering securities"
Stock options financial
"Stock options were granted on March 5, 2024, with the remaining options to purchase 13,125 ordinary shares vesting..."
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did Brainsway (BWAY) CTO Moiseyev Gilad report?
Brainsway CTO Moiseyev Gilad reported exercising options for 7,500 Ordinary Shares and selling 5,000 shares. The filing also shows shares retained by the company for tax and exercise costs and remaining options and RSUs that vest in future periods.
What stock options did the Brainsway (BWAY) CTO exercise in this Form 4?
On May 25, 2026, the CTO exercised stock options for 7,500 Ordinary Shares at an exercise price of NIS 11.17 per share. These options were part of a grant dated March 5, 2024, with remaining options vesting quarterly until March 5, 2028.
What unexercised Brainsway (BWAY) options and RSUs remain for the CTO?
Footnotes state the CTO has remaining options to purchase 13,125 Ordinary Shares, vesting quarterly until March 5, 2028. He also holds several tranches of unvested RSUs, each representing a contingent right to receive one Ordinary Share over future quarterly vesting schedules.